A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Clinical trial NCT05751512 · UNKNOWN

Trial details

NCT number: NCT05751512
Sponsor: Shanghai Miracogen Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2023-03-01
Primary completion: 2025-08-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.